EYPT EyePoint
EyePoint earnings company data as of 1:01 PM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by EYPT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $72K bought by 2 insiders
- $942K sold by 1 insider outside a trading plan
- $1.1M sold by 2 insiders under 10b5-1 plans
-
Karen L. Zaderej DirectorBuy$52K 10,600 shares at $4.93 +28% to stakeTraded Aug 18 Filed Aug 18
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$73K 4,875 shares at $15.01 100% of stakeTraded Jun 30 Filed Jul 2
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$37K 2,437 shares at $15.00 100% of stakeTraded Apr 17 Filed Apr 20
-
Jay S. Duker CEOBuy$20K 1,500 shares at $13.15 +1.5% to stakeTraded Mar 16 Filed Mar 16
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$44K 2,438 shares at $17.87 100% of stakeTraded Mar 4 Filed Mar 5
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$37K 2,437 shares at $15.00 100% of stakeTraded Feb 17 Filed Feb 18
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$727K 42,544 shares at $17.10 100% of stakeTraded Jan 5 Filed Jan 7
-
Cormorant Asset Management, LP Insider, +2 joint filersSale$942K 60,000 shares at $15.70 0.7% of stakeTraded Dec 4, 2025 Filed Dec 8, 2025
-
Nancy Lurker DirectorPlanned sale$140K 9,300 shares at $15.11 4.3% of stakeTraded Dec 4, 2025 Filed Dec 5, 2025
-
Nancy Lurker DirectorPlanned sale$10K 700 shares at $14.95 0.3% of stakeTraded Nov 26–28 Filed Dec 1, 2025
-
Ramiro Ribeiro Chief Medical OfficerPlanned sale$32K 2,722 shares at $11.61 100% of stakeTraded Nov 11, 2025 Filed Nov 12, 2025
Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 9 share withholdings for taxes, 6 gifts, and 4 other transactions.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,2.05,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.